Trinity Translational Medicine Institute - Symposium 2019
Prof. Mark Tangney
Mark is a Principal Investigator within the Cork Cancer Research Centre in UCC where his research team investigates cancer therapies using microbes. With a PhD in microbiology and an MBA from UCC, his interests include the development of tumour-specific drug delivery technology utilising bacteria or viruses. He has worked for a number of years at various international institutions (Los Angeles, Boston, Copenhagen) and has published extensively in the field of cancer therapy and microbiology. Mark is a member of the executive council of the International Society for Cell and Gene Therapy of Cancer (ISCGT), a scientific committee member of the European Society for Gene & Cell Therapy (ESGCT), a council member of the Irish Association for Cancer Research (IACR), Vice-President of the Irish Society for Gene and Cell Therapy (ISGCT) and a member of the editorial board of several international journals (Human Gene Therapy, Current Gene Therapy, Bioengineered Bugs, Biomarkers in Cancer).